02 Dec March-in rights under the Bayh-Dole Act undermine the US drug development sector without lowering drug costs
Joseph P. Allen
Nature Biotechnology, 12/2/2025...
Joseph P. Allen
Nature Biotechnology, 12/2/2025...
Robert Enderle
TG Daily, 11/19/2025...
Clare Zhang
American Institute of Physics, 10/21/2025...
Maaisha Osman
Inside Health Policy, 10/20/2025...
Dr. Nathan M. Greenfield
University World News, 10/16/2025...
Adam Kelnhofer
WisBusiness, 10/14/2025...
Allison Braden
Charlotte Magazine, 10/13/2025...
Marisa Woutersen
Life Sciences Intellectual Property Review, 10/13/2025...
Joseph Allen
IPWatchdog, 10/2/2025...
Ryan Davis
Law360, 9/19/2025...